These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1577222)

  • 1. A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating duodenal ulcers.
    Okada M; Arita M; Iida M; Yao T; Sakurai T; Hoshiko K; Maeda K; Okada Y; Sakamoto K
    Gastroenterol Jpn; 1992 Apr; 27(2):179-86. PubMed ID: 1577222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating gastric ulcers.
    Okada M; Yao T; Sakurai T; Arita M; Okabe N; Iida M; Okada Y; Koga T
    Am J Gastroenterol; 1992 Aug; 87(8):1009-13. PubMed ID: 1642202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of single morning and single bedtime doses of famotidine on intragastric acidity in patients with gastric ulcer.
    Arita M; Okada M; Motomura A; Matsui T; Hosiko K; Yao T
    Am J Gastroenterol; 1994 Feb; 89(2):214-9. PubMed ID: 8304306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between single morning and bedtime doses of 40 mg famotidine for the treatment of duodenal ulcer.
    Marenco G; Menardo G; Pallini P; Rossini FP; Saggioro A
    Aliment Pharmacol Ther; 1989 Jun; 3(3):285-91. PubMed ID: 2520624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nocturnal acidity is important but not essential for duodenal ulcer healing.
    Bianchi Porro G; Parente F; Sangaletti O
    Gut; 1990 Apr; 31(4):397-400. PubMed ID: 2186980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine.
    Savarino V; Mela GS; Scalabrini P; Fera G; Zentilin P; Sumberaz A; Celle G
    Eur J Clin Pharmacol; 1988; 35(2):203-7. PubMed ID: 3191940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.
    Savarino V; Mela GS; Zentilin P; Sumberaz A; Cutela P; Celle G
    Digestion; 1991; 48(3):141-8. PubMed ID: 1916034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind study comparing famotidine with ranitidine in the treatment of active duodenal ulcer disease.
    McCullough AJ
    Am J Med; 1986 Oct; 81(4B):17-24. PubMed ID: 2877570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
    Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
    Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous 24-hour intragastric pH monitoring in the evaluation of the effect of a nightly dose of famotidine, ranitidine and placebo on gastric acidity of patients with duodenal ulcer.
    Savarino V; Mela GS; Scalabrini P; Di Timoteo E; Magnolia MR; Celle G
    Digestion; 1987; 37(2):103-9. PubMed ID: 3305114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.
    Celle G; Savarino V; Mela GS; Scalabrini P; Sumberaz A; Fera G; Zentilin P
    Scand J Gastroenterol; 1988 May; 23(4):385-90. PubMed ID: 2898167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
    Alcalá-Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
    Digestion; 1989; 42(2):79-85. PubMed ID: 2670647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
    Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
    Watanabe Y; Tsumura H; Sasaki H; Morimoto T
    Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
    Masoero G; Rossanino A; Arossa W; De la Pierre M
    J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC; Roudot-Thoraval F; Stanescu L; Deharvengt MC; Elouaer Blanc L
    Gut; 1994 Jun; 35(6):750-4. PubMed ID: 8020798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.